Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
As of close of business last night, Myriad Genetics, Inc’s stock clocked out at $16.36, down -1.45% from its previous closing price of $16.60. In other words, the price has decreased by -$1.45 from its previous closing price. On the day, 0.54 million shares were traded. MYGN stock price reached its highest trading level at $16.56 during the session, while it also had its lowest trading level at $16.07.
Ratios:
To gain a deeper understanding of MYGN’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.73 and its Current Ratio is at 1.90. In the meantime, Its Debt-to-Equity ratio is 0.20 whereas as Long-Term Debt/Eq ratio is at 0.18.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Morgan Stanley on September 19, 2024, initiated with a Equal-Weight rating and assigned the stock a target price of $32.
On August 28, 2024, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $35.
On June 27, 2024, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $29.Scotiabank initiated its Sector Outperform rating on June 27, 2024, with a $29 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Oct 11 ’24 when DIAZ PAUL J sold 15,000 shares for $22.93 per share. The transaction valued at 343,950 led to the insider holds 962,378 shares of the business.
DIAZ PAUL J bought 15,000 shares of MYGN for $343,950 on Oct 11 ’24. On Aug 21 ’24, another insider, Ancona Margaret, who serves as the Officer of the company, bought 11,538 shares for $27.82 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MYGN now has a Market Capitalization of 1511184768 and an Enterprise Value of 1532536320. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.81 while its Price-to-Book (P/B) ratio in mrq is 2.03. Its current Enterprise Value per Revenue stands at 1.861 whereas that against EBITDA is -45.208.
Stock Price History:
Over the past 52 weeks, MYGN has reached a high of $29.30, while it has fallen to a 52-week low of $14.72. The 50-Day Moving Average of the stock is -20.03%, while the 200-Day Moving Average is calculated to be -29.35%.
Shares Statistics:
It appears that MYGN traded 794.42K shares on average per day over the past three months and 749730 shares per day over the past ten days. A total of 91.00M shares are outstanding, with a floating share count of 87.61M. Insiders hold about 3.76% of the company’s shares, while institutions hold 100.22% stake in the company. Shares short for MYGN as of 1731628800 were 3694325 with a Short Ratio of 4.65, compared to 1728950400 on 4494424. Therefore, it implies a Short% of Shares Outstanding of 3694325 and a Short% of Float of 5.6799997.
